Drug-Target Information
Drug Name Target Name Drug Type Target Type Source Drug MeSHID Interaction Score Drug Status Target Action
3,4-di-(4-methoxyphenyl)-1h-pyrrole-2,5-dione g2/mitotic-specific cyclin b1 NA Patented-recorded target TTD NA NA investigative unknown
3,4-di-(4-methoxyphenyl)-1h-pyrrole-2,5-dione g1/s-specific cyclin-d1 NA Clinical trial target TTD NA NA investigative unknown
3,4-di-(4-methoxyphenyl)-1h-pyrrole-2,5-dione cyclin-dependent kinase 1 NA Clinical trial target TTD NA NA investigative unknown
3,4-di-(4-methoxyphenyl)-1h-pyrrole-2,5-dione cyclin-dependent kinase 2 NA Clinical trial target TTD NA NA investigative unknown
3,4-di-(4-methoxyphenyl)-1h-pyrrole-2,5-dione cyclin-dependent kinase 4 NA Successful target TTD NA NA investigative unknown
3,4-di-(4-methoxyphenyl)-1h-pyrrole-2,5-dione cyclin-dependent kinase 6 NA Successful target TTD NA NA investigative unknown
3,4-di-(4-methoxyphenyl)-1h-pyrrole-2,5-dione epidermal growth factor receptor NA Successful target TTD NA NA investigative unknown
3,4-di-(4-methoxyphenyl)-1h-pyrrole-2,5-dione erbb2 messenger rna NA Clinical trial target TTD NA NA investigative unknown
3,4-di-(4-methoxyphenyl)-1h-pyrrole-2,5-dione vascular endothelial growth factor receptor 2 NA Successful target TTD NA NA investigative unknown
3,4-di-(4-methoxyphenyl)-1h-pyrrole-2,5-dione protein kinase c alpha NA Successful target TTD NA NA investigative unknown
3,4-di-(4-methoxyphenyl)-1h-pyrrole-2,5-dione protein kinase c epsilon NA Successful target TTD NA NA investigative unknown
3,4-di-(4-methoxyphenyl)-1h-pyrrole-2,5-dione protein kinase c gamma NA Successful target TTD NA NA investigative unknown
3,4-di-(4-methoxyphenyl)-1h-pyrrole-2,5-dione angiopoietin 1 receptor NA Clinical trial target TTD NA NA investigative unknown
click here to return to the previous page